IL103436A - Pyrimidinones are compressed in converted cycles, their preparation and pharmaceutical preparations containing them - Google Patents

Pyrimidinones are compressed in converted cycles, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL103436A
IL103436A IL10343692A IL10343692A IL103436A IL 103436 A IL103436 A IL 103436A IL 10343692 A IL10343692 A IL 10343692A IL 10343692 A IL10343692 A IL 10343692A IL 103436 A IL103436 A IL 103436A
Authority
IL
Israel
Prior art keywords
compound
formula
methyl
carbon atoms
mixture
Prior art date
Application number
IL10343692A
Other languages
English (en)
Hebrew (he)
Other versions
IL103436A0 (en
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/782,025 external-priority patent/US5149699A/en
Priority claimed from GB9207560A external-priority patent/GB2265899A/en
Priority claimed from US07/901,485 external-priority patent/US5256654A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL103436A0 publication Critical patent/IL103436A0/xx
Publication of IL103436A publication Critical patent/IL103436A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10343692A 1991-10-24 1992-10-15 Pyrimidinones are compressed in converted cycles, their preparation and pharmaceutical preparations containing them IL103436A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/782,025 US5149699A (en) 1991-10-24 1991-10-24 Substituted pyridopyrimidines useful as antgiotensin II antagonists
GB9207560A GB2265899A (en) 1992-04-07 1992-04-07 Substituted pyrimidines
US07/901,485 US5256654A (en) 1991-10-24 1992-06-25 Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists

Publications (2)

Publication Number Publication Date
IL103436A0 IL103436A0 (en) 1993-03-15
IL103436A true IL103436A (en) 1996-03-31

Family

ID=27266132

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10343692A IL103436A (en) 1991-10-24 1992-10-15 Pyrimidinones are compressed in converted cycles, their preparation and pharmaceutical preparations containing them

Country Status (21)

Country Link
EP (1) EP0539086B1 (sk)
JP (1) JP3240192B2 (sk)
KR (1) KR100286624B1 (sk)
CN (2) CN1039324C (sk)
AT (1) ATE161537T1 (sk)
AU (1) AU653635B2 (sk)
CA (1) CA2080705C (sk)
DE (1) DE69223734T2 (sk)
DK (1) DK0539086T3 (sk)
ES (1) ES2111617T3 (sk)
FI (1) FI103971B1 (sk)
GR (1) GR3025926T3 (sk)
HK (1) HK1003031A1 (sk)
HU (2) HU218786B (sk)
IL (1) IL103436A (sk)
LV (1) LV12047B (sk)
NO (1) NO301275B1 (sk)
SG (1) SG47626A1 (sk)
SK (1) SK322192A3 (sk)
TW (1) TW226375B (sk)
UA (1) UA27748C2 (sk)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08500323A (ja) * 1991-11-18 1996-01-16 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー Ａ▲ｉｉ▼受容体アンタゴニストの合成のためのテトラゾリルフェニルボロン酸中間体
DK0618207T3 (da) * 1993-03-24 1999-08-30 American Home Prod Substituerede pyridopyrimidiner som antihypertensiva
DK0782996T3 (da) * 1994-09-20 1999-09-20 Wakunaga Seiyaku Kk Fremgangsmåde til fremstilling af N-biphenylmethylthiadiazolinderivat eller salt deraf og mellemprodukt til fremstilling af
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AR033390A1 (es) 2000-08-22 2003-12-17 Novartis Ag Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
GB0402262D0 (en) 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
US20080161321A1 (en) 2004-03-17 2008-07-03 David Louis Feldman Use of Renin Inhibitors in Therapy
EP2248520A3 (en) 2004-10-08 2010-11-17 Novartis AG Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
MX2009012917A (es) * 2007-06-07 2010-01-14 Sigma Tau Ind Farmaceuti Derivados de 5beta, 14-beta-androestano utiles para el tratamiento de restenosis despues de angioplastia o endoarterectomia y enfermedades debido a la fibrosis de organos.
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
AP2014007766A0 (en) 2011-12-15 2014-07-31 Takeda Pharmaceuticals Usa Inc Combination os azilsartan and chlorthlidone for treating hypertension black patients
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
WO1991012001A1 (en) * 1990-02-13 1991-08-22 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted benzyl element
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
FI924397A (fi) 1993-04-25
UA27748C2 (uk) 2000-10-16
EP0539086B1 (en) 1997-12-29
KR930007949A (ko) 1993-05-20
DE69223734T2 (de) 1998-04-16
FI103971B (fi) 1999-10-29
DE69223734D1 (de) 1998-02-05
CA2080705C (en) 2002-12-03
ES2111617T3 (es) 1998-03-16
NO301275B1 (no) 1997-10-06
AU2607992A (en) 1993-04-29
GR3025926T3 (en) 1998-04-30
HU218786B (hu) 2000-12-28
HU211915A9 (en) 1996-01-29
LV12047B (en) 1998-08-20
LV12047A (lv) 1998-05-20
NO924121D0 (no) 1992-10-23
DK0539086T3 (da) 1998-02-02
JPH05222039A (ja) 1993-08-31
NO924121L (no) 1993-04-26
ATE161537T1 (de) 1998-01-15
EP0539086A3 (en) 1993-06-16
TW226375B (sk) 1994-07-11
SK280292B6 (sk) 1999-11-08
SG47626A1 (en) 1998-04-17
KR100286624B1 (ko) 2001-05-02
CN1039324C (zh) 1998-07-29
IL103436A0 (en) 1993-03-15
SK322192A3 (en) 1999-11-08
JP3240192B2 (ja) 2001-12-17
HU9203161D0 (en) 1992-12-28
CN1175414A (zh) 1998-03-11
AU653635B2 (en) 1994-10-06
EP0539086A2 (en) 1993-04-28
CA2080705A1 (en) 1993-04-25
FI924397A0 (fi) 1992-09-30
HUT62893A (en) 1993-06-28
CN1072682A (zh) 1993-06-02
HK1003031A1 (en) 1998-09-30
FI103971B1 (fi) 1999-10-29

Similar Documents

Publication Publication Date Title
EP0539086B1 (en) Condensed pyrimidine derivatives and their use as angiotensine II antagonists
US5149699A (en) Substituted pyridopyrimidines useful as antgiotensin II antagonists
JP3260415B2 (ja) アンギオテンシンｉｉ拮抗作用を有する複素環化合物
US5225414A (en) Substituted azoles, a process for their preparation, and their use
EP0611368B1 (en) Substituted aminopyrimidines as angiotensin ii antagonists
WO1993008170A1 (en) Substituted heterocycles as angiotensin ii antagonists
KR100251822B1 (ko) 고혈압치료제로서의 치환된 피리도피리미딘 및 이를 포함하는 약제학적 조성물
US5330989A (en) Heterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivatives
SK73293A3 (en) Benzimidazoles, process for their preparation and medicaments contained this compounds
US5283242A (en) Substituted benzimidazoles and quinazolines as antihypertensives
US5256654A (en) Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
EP0618207B1 (en) Substituted pyridopyrimidines as antihypertensives
GB2265899A (en) Substituted pyrimidines
US6096754A (en) N-3 substituted pyrimidin-4-ones with AII antagonistic activity
WO1993024501A1 (en) Phosphorus containing heterocyclic compounds as angiotensins antagonists
WO1993024487A1 (en) Nitrogen containing heterocyclic compounds as angiotensin-ii-antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees